Nucleic acid-based therapy for coronavirus disease 2019
The coronavirus disease 2019 (COVID-19), the pandemic that originated in China has already spread into more than 190 countries, resulting in huge loss of human life and many more are at the stake of losing it; if not intervened with the best therapeutics to contain the disease. For that aspect, vari...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15615
- Acceso en línea:
- https://doi.org/10.1016/j.heliyon.2020.e05007
http://hdl.handle.net/20.500.12010/15615
- Palabra clave:
- Microbiology
Biotechnology
Molecular biology
Epidemiology
Virology
Regenerative medicine
Covid-19
SARS-CoV-2
Nucleic acid based therapy
siRNA
Ribozymes
DNAzymes
Aptamers
Antisense
Oligonucleotide
COVID-19 (Enfermedad)
Infecciones por coronavirus
Vacunas - Pruebas
- Rights
- License
- Abierto (Texto Completo)